ArticleBiomarker research2023

Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency followed by cisplatin and nab paclitaxel.

Jessica D Lang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.